4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001144204-19-047100
CIK 0001508381other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 10:48 AM ET
Size
5.2 KB
Accession
0001144204-19-047100
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-09-30$6.80/sh+76,225$518,330→ 1,277,637 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (1)
- [F1]Effective as of September 30, 2019, an aggregate amount of $518,333 of principal and accrued interest in convertible promissory notes issued to RGD Investissements (the "Notes") converted in accordance with their terms into 76,225 shares of the Issuer's common stock.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 10:48 AM ET
- Size
- 5.2 KB